Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01111110 · ClinicalTrials.gov registry record · NA
Response to Albuterol Delivered Through an Anti-static Valved Holding Chamber During Nocturnal Bronchospasm
A NA study, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 88
- Enrollment target
NCT01111110 is a NA study that has completed, run by University of Florida. The registered enrollment target is 88 participants.
The verdict
NCT01111110, a NA study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 88 participants
- Enrollment target
Study Summary
Delivery of HFA albuterol through an antistatic valved holding chamber (VHC) will improve bronchodilator response during nocturnal bronchospasm.
Interventions
- DEVICE anti-static then static
- DEVICE Static then anti-static chamber
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2008-05 |
| Est. Completion | 2010-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01111110
The ClinicalTrials.gov registry entry for NCT01111110 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which anti-static then static is the first listed.
NCT01111110 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01111110 about?
NCT01111110 is a clinical study titled "Response to Albuterol Delivered Through an Anti-static Valved Holding Chamber During Nocturnal Bronchospasm". Delivery of HFA albuterol through an antistatic valved holding chamber (VHC) will improve bronchodilator response during nocturnal bronchospasm.
What is the current status of trial NCT01111110?
This trial is currently completed. It is a NA study. The enrollment target is 88 participants. The study started on 2008-05. Estimated completion is 2010-03.
What interventions are being tested in trial NCT01111110?
The interventions under investigation include: anti-static then static (DEVICE), Static then anti-static chamber (DEVICE).
Who is sponsoring clinical trial NCT01111110?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.